Company: AIP
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048977
Chunk: 31

Company: Arteris, Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 1
Chunk 31
---
)(24,494)Interest expense(49)(55)(139)(199)Other income (expense), net636 775 2,140 2,576 Loss before income taxes and loss from equity method investment(8,127)(7,199)(22,669)(22,117)Loss from equity method investment, net of tax484 580 2,079 2,064 Provision for (benefit from) income taxes380 (92)1,494 1,253 Net loss$(8,991)$(7,687)$(26,242)$(25,434)

(1)Includes stock-based compensation expense as follows: 

Three Months EndedNine Months EndedSeptember 30,September 30,2025202420252024(in thousands)Cost of revenue$228 $221 $665 $596 Research and development2,095 2,154 5,994 5,550 Sales and marketing1,335 850 3,352 2,230 General and administrative1,298 1,165 3,754 3,431 Total stock-based compensation$4,956 $4,390 $13,765 $11,807 

27

The following table summarizes our results of operations as a percentage of total revenue for each of the periods indicated:

Three Months EndedNine Months EndedSeptember 30,September 30,2025202420252024(as a percentage of total revenue)Total revenue100 %100 %100 %100 %Cost of revenue10 10 10 10 Gross profit90 90 90 90 Operating expenses:Research and development73 81 73 79 Sales and marketing39 34 39 37 General and administrative28 29 27 32 Total operating expenses140 144 139 148 Loss from operations(50)(54)(49)(58)Interest expense— — — — Other income (expense), net4 5 4 6 Loss before income taxes and loss from equity method investment(46)(49)(45)(52)Loss from equity method investment, net of tax3 4 4 5 Provision for (benefit from) income taxes2 (1)3 3 Net loss(51)%(52)%(52)%(60)%

Comparison of the Three Months Ended September 30, 2025 and 202